Fluconazole mouthrinses for oral candidiasis in postirradiation, transplant, and other patients

Joel B. Epstein*, Meir Gorsky, John Caldwell

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Objective. Oral candidiasis is associated with multiple local and systemic factors. Morbidity and deaths, in high-risk patients, may be prevented by recognition and adequate management. Fluconazole is a systemic antifungal medication that demonstrated clinical advantages in rinsing before swallowing. The purpose of the present study was to evaluate the clinical efficacy of fluconazole aqueous mouthrinses to treat oral candidiasis. Methods. Ten women and 9 men diagnosed with oral candidiasis used fluconazole (2 mg/mL) aqueous solution 3 times per day as a rinse and-spit topical treatment. The outcome was assessed after 1 week of treatment. Results. Complete symptomatic and clinical relief was noted in 94% of the patients, and a mycologic cure was documented in all but 1 patient. No side effects were reported. Oral rinses with fluconazole suspension may be useful to manage patients with dry mouth or those who have difficulties in swallowing caused by oral candidiasis. Conclusions. Further double-blind studies are needed to establish the optimal treatment regimen and the usefulness of fluconazole mouthrinses in patients with different risk factors for infection.

Original languageEnglish
Pages (from-to)671-675
Number of pages5
JournalOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
Issue number6
StatePublished - 2002


Dive into the research topics of 'Fluconazole mouthrinses for oral candidiasis in postirradiation, transplant, and other patients'. Together they form a unique fingerprint.

Cite this